The adverse event binder sat on the conference table between them, three tabbed reports inside, and Claire had spent twenty minutes pretending to read it when what she actually wanted was to throw it through the window.
"Three," she said. "You told me you'd hand over everything by Friday."
"I did." Ethan Cole didn't look up from his laptop. The sleeve of his lab coat was rolled to the elbow; a pen clipped his pocket, and the ink on his fingers said he'd come straight from rounds. "Everything the sponsor transmitted to me."
"Nineteen, Ethan. I've counted nineteen discharges that should have triggered a report."
"Then count them somewhere else. The protocol is what it is."
She slid a stapled page across the table. Two columns, tight formatting, the kind of document she'd built a hundred times and never once loved. "I want to amend it. Before we lock enrollment."
He finally looked. Read it. Read it again. His jaw worked once, and then he set the paper down flat, squared to the table's edge, the way a man sets down something he intends to pick back up and throw.
"Gender-stratified variables," he said. "Atypical presentation flags. And a re-review clause on every female subject under fifty who scored under the cutoff."
"Yes."
"No."
"You didn't even—"
"I read it." He stood, and the chair scraped hard enough that the glass wall trembled. "This is a confirmatory trial, Claire. It exists to do one thing: confirm that the device performs as the prior data says it does. The moment we change the endpoints, we're no longer confirming anything. We're running a new study."
"Good. Maybe we should be."
"You don't understand what you're asking for." He picked up his coffee, found it empty, and set it down with the same exact care. "A protocol amendment means IRB resubmission. Site re-consenting. Four to six months minimum before we enroll a single additional subject. Six months in which the device sits on a shelf while people who could have been screened by it aren't."
"People who could have been screened by it," Claire repeated. "You mean like Yolanda Alvarez."
The room went very quiet. Through the glass, a resident walked past with a folder, oblivious.
"That's not fair," Ethan said.
"It's accurate."
"Those aren't the same thing."
"So explain the difference to me." She stood too, because sitting made her feel like she was being managed. "Explain how adding a variable that catches women you and I both know are falling through — explain how that's worse than fast approval of a device that gets them killed."
He was at the door before she finished. She followed him into the hallway, past the nurses' station, past a transport tech pushing a gurney with a squeaking wheel, and neither of them lowered their voice enough for it to be polite.
"You think I don't want it fixed?" He stopped so abruptly she almost hit him. Close enough that she could see the tiredness banked behind his eyes, the fine gray at his temples that hadn't been there in the residency photo someone had once shown her. "You think I spend my nights writing down every name because I'm satisfied with the system?"
"Then act like it."
"I am acting like it. Every single day. Most of the time it looks like not blowing up the one study that could actually make this thing safer down the line." He pointed back toward the conference room. "That page you wrote? It doesn't just delay approval. It flags the company for scrutiny. It triggers a data integrity review. It gives every lawyer in Boston a reason to subpoena this trial, and the second that happens, the whole dataset is poison. Nothing the device learns after that is admissible. You'd be killing the fix to prove there's a problem."
"You'd be shipping the problem to prove there's a fix."
Something moved through his face, quick and shut-down.
"Your amendment won't get through Mark anyway," he said, quieter. "You know that. So what are we doing here?"
"I don't know, Ethan." Her voice cracked, just slightly, and she hated it. "Maybe I'm asking whether the man who takes handwritten notes on every patient he releases actually cares, or whether he just feels bad enough to keep a notebook."
He went still. Absolutely still, in a way she'd never seen on him, and in the hallway light his face looked carved out.
"I care more than you know," he said. Flat. No heat in it at all. "That's the whole problem with you, Bennett. You think caring looks like you."
He walked. She stood there with her hands at her sides, holding a page he hadn't taken.
She went back to the conference room and gathered the binder. Three reports. She photographed all three against the table edge for scale and lighting, then the cover, then the spine, then closed it and put it exactly where he'd left it.
Then she went to her office and opened her personal cloud drive, the one that lived outside the company's single sign-on, the one synced to a personal account that no legal hold would ever touch first.
*CS_validation_notes_draft_v1.*
She added a new section header and typed for forty minutes straight.
*6.1 Protocol amendment proposed 04/18, gender-stratified variables + atypical presentation re-review. Rejected by site PI. Rationale cited: IRB delay 4–6 mo, data integrity exposure. Note: his stated concern was not the science. It was that amendment creates a subpoena trigger.*
*6.2 Ask: did the PI reject on clinical grounds or instructed grounds? Recommend independent verification.*
*6.3 Count discrepancy: binder holds 3 AEs. Discharge records reviewed by observation suggest 19 candidates. Two more still unreconciled.*
*6.4 If protocol cannot be amended on paper, data can still be gathered off paper. Begin structured patient interviews, informed consent, personal custody. Do not store in company systems.*
She stopped. Read it back. The sentence sat there in the white of the document like a headline she hadn't meant to write.
She'd spent her whole career inside the paper. Protocols, submissions, gates, the whole Rube Goldberg machine that turned an idea into a cleared device. Everything she knew how to do was official. Everything she knew how to do required the signatures of men who were watching the launch calendar.
But Ethan had said something true, under the anger: the study couldn't survive scrutiny, and the study was the only thing that could make the device safer. Which meant the fix couldn't come from inside the study.
It had to come from the patients.
She pulled up the clinic schedule. Filtered for women under fifty, cardiology, the last ninety days. Twenty-three names scrolled past. She recognized number eight — Marisol Vega, the young woman Ethan had admitted on a negative troponin, the one whose chart he'd touched twice with two fingers like a man checking a pulse.
Claire opened a new blank document, titled it *Interview_Form_01*, and built it from scratch: chief complaint, symptom onset, where it started, what it felt like, what she was told, where she was sent, what happened next. Nothing leading. Nothing that could be called coaching. Just questions, and a recording consent line at the bottom.
She printed two copies, because one felt like a plan and two felt like a decision.
Her phone buzzed. Mark, in the group thread: *Confirmatory trial enrollment on track for 6/1. Great work team.* A thumbs-up from someone in regulatory. A thumbs-up from someone in legal.
Claire closed the thread. On her lanyard, the pink ribbon caught the desk lamp and glowed a little, cheap plastic, worth nothing.
She typed one more line in the private file, last line, the kind you write and then close the laptop on.
*6.5 Starting next week. He'll find out. Let him.*
She reached for the phone to schedule the first appointment, and her hand hovered over the name at the top of the list: not Marisol. A Mrs. Chen, sixty-two, whose last two ED visits both ended with *non-cardiac chest pain, discharge home*.
Claire scheduled it for Monday, 7 a.m., before the floor got busy.
Then she sat in the dark office with the ribbon glowing and understood, with the plain clarity of a woman signing something, that she had just stopped working on the trial.
She had started a second one.